Compare NKTR & DAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTR | DAO |
|---|---|---|
| Founded | 1990 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 1996 | 2019 |
| Metric | NKTR | DAO |
|---|---|---|
| Price | $72.79 | $14.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $146.67 | N/A |
| AVG Volume (30 Days) | ★ 481.5K | 73.9K |
| Earning Date | 05-07-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $307,711,000.00 | N/A |
| Revenue This Year | N/A | $12.24 |
| Revenue Next Year | N/A | $14.60 |
| P/E Ratio | ★ N/A | $72.35 |
| Revenue Growth | ★ 86.00 | N/A |
| 52 Week Low | $33.40 | $8.38 |
| 52 Week High | $109.00 | $18.94 |
| Indicator | NKTR | DAO |
|---|---|---|
| Relative Strength Index (RSI) | 49.04 | 39.56 |
| Support Level | $70.24 | $9.26 |
| Resistance Level | $76.49 | $18.79 |
| Average True Range (ATR) | 2.86 | 1.03 |
| MACD | -0.17 | -0.37 |
| Stochastic Oscillator | 36.36 | 4.57 |
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.